VIPLAV PRASHANT and MEERA K S, “SERUM FERRITIN LEVEL AND MYELOPEROXIDASE ACTIVITY IN TYPE 2 DIABETIC MALES ON ORAL HYPOGLYCEMIC AGENTS”, ijpbs, vol. 5, no. 4, pp. 373–386, Dec. 2014.